enprofylline has been researched along with Arrhythmia in 2 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Excerpt | Relevance | Reference |
---|---|---|
"Enprofylline, a drug without adenosine antagonism and theophylline, a potent adenosine antagonist, were compared, double-blind, randomized, in acute asthma (n = 33)." | 9.06 | Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma. ( Amundsen, T; Brenna, E; Eriksson, G; Holte, S; Källén, AG; Naustdal, T; Persson, CG; Storstein, L; Syvertsen, U; Vilsvik, JS, 1990) |
"Long-term ambulatory Holter-monitoring was used to evaluate the arrhythmogenic effects of beta 2-agonist therapy, alone and in combination with a xanthine derivative, theophylline or enprofylline." | 6.66 | Cardiac arrhythmias in patients with mild-to-moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprofylline or theophylline. ( Conradson, TB; Eklundh, G; Olofsson, B; Pahlm, O; Persson, G, 1985) |
"Enprofylline, a drug without adenosine antagonism and theophylline, a potent adenosine antagonist, were compared, double-blind, randomized, in acute asthma (n = 33)." | 5.06 | Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma. ( Amundsen, T; Brenna, E; Eriksson, G; Holte, S; Källén, AG; Naustdal, T; Persson, CG; Storstein, L; Syvertsen, U; Vilsvik, JS, 1990) |
"Long-term ambulatory Holter-monitoring was used to evaluate the arrhythmogenic effects of beta 2-agonist therapy, alone and in combination with a xanthine derivative, theophylline or enprofylline." | 2.66 | Cardiac arrhythmias in patients with mild-to-moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprofylline or theophylline. ( Conradson, TB; Eklundh, G; Olofsson, B; Pahlm, O; Persson, G, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vilsvik, JS | 1 |
Persson, CG | 1 |
Amundsen, T | 1 |
Brenna, E | 1 |
Naustdal, T | 1 |
Syvertsen, U | 1 |
Storstein, L | 1 |
Källén, AG | 1 |
Eriksson, G | 1 |
Holte, S | 1 |
Conradson, TB | 1 |
Eklundh, G | 1 |
Olofsson, B | 1 |
Pahlm, O | 1 |
Persson, G | 1 |
2 trials available for enprofylline and Arrhythmia
Article | Year |
---|---|
Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Double- | 1990 |
Cardiac arrhythmias in patients with mild-to-moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprofylline or theophylline.
Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind | 1985 |